These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 6839982

  • 1. [Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer].
    Krieger G, Wander HE, Prangen M, Bandlow G, Beyer JH, Nagel GA.
    Dtsch Med Wochenschr; 1983 Apr 22; 108(16):610-4. PubMed ID: 6839982
    [Abstract] [Full Text] [Related]

  • 2. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
    Staab HJ, Ahlemann LM, Koch HL, Anderer FA.
    Oncodev Biol Med; 1980 Apr 22; 1(3):151-60. PubMed ID: 7279702
    [Abstract] [Full Text] [Related]

  • 3. [Carcinoembryonic antigens (CEA) in patients with metastatic breast cancer under endocrine and therapeutic treatment (author's transl)].
    Pompecki R, Schröder G, Garbrecht M, Frahm H.
    Dtsch Med Wochenschr; 1978 Apr 07; 103(14):620-2. PubMed ID: 639696
    [Abstract] [Full Text] [Related]

  • 4. Comparison of CA15-3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer.
    Tondini C, Hayes DF, Gelman R, Henderson IC, Kufe DW.
    Cancer Res; 1988 Jul 15; 48(14):4107-12. PubMed ID: 3164256
    [Abstract] [Full Text] [Related]

  • 5. Serial CEA determinations as an aid in postoperative therapy management of patients with early breast cancer.
    Ahlemann LM, Staab HJ, Anderer FA.
    Biomedicine; 1980 Dec 15; 32(4):194-9. PubMed ID: 7470582
    [Abstract] [Full Text] [Related]

  • 6. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
    Lamerz R, Leonhardt A, Ehrhart H, von Lieven H.
    Oncodev Biol Med; 1980 Dec 15; 1(2):123-35. PubMed ID: 7279699
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Human tissue polypeptide antigen in breast cancer.
    Nemoto T, Constantine R, Chu TM.
    J Natl Cancer Inst; 1979 Dec 15; 63(6):1347-50. PubMed ID: 292806
    [Abstract] [Full Text] [Related]

  • 9. Elevated serum carcinoembryonic antigen and prognosis of breast cancer patients postmastectomy.
    Paulick R, Caffier H.
    Cancer Detect Prev; 1988 Dec 15; 11(3-6):311-7. PubMed ID: 3390852
    [Abstract] [Full Text] [Related]

  • 10. Carcinoembryonic antigen in tissue and serum from breast cancer patients relationship with steroid receptors and clinical applications in the prognosis and early diagnosis of relapse.
    Molina R, Farrus B, Filella X, Jo J, Zanón G, Pahisa J, Latre M, Muñoz M, Ballesta AM.
    Anticancer Res; 1999 Dec 15; 19(4A):2557-62. PubMed ID: 10470194
    [Abstract] [Full Text] [Related]

  • 11. Immunotherapy prolongs the serum CEA-TPA-CA15.3 lead time at the metastatic progression in endocrine-dependent breast cancer patients: a retrospective longitudinal study.
    Nicolini A, Carpi A, Ferrari P, Rossi G.
    Cancer Lett; 2008 May 08; 263(1):122-9. PubMed ID: 18241981
    [Abstract] [Full Text] [Related]

  • 12. Carcinoembryonic antigen (CEA) measurements as an aid to management of patients with lung cancer treated by radiotherapy.
    Ahlemann LM, Staab HJ, Koch HL, Anderer FA.
    Oncodev Biol Med; 1980 May 08; 1(3):143-50. PubMed ID: 7279701
    [Abstract] [Full Text] [Related]

  • 13. [Carcinoembryonic antigen (CEA) in patients with lung cancer: correlation with tumour extent and response to treatment (author's transl)].
    Gropp C, Lehmann FG, Havemann K.
    Dtsch Med Wochenschr; 1977 Jul 29; 102(30):1079-82. PubMed ID: 891388
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Radioimmunoassay of carcinoembryonic antigen in the evaluation of the effectiveness of breast cancer treatment].
    Polevaia EB, Ivanov VM, Koposova TL, Gabuniia RI, Chinareva IV.
    Vopr Onkol; 1984 Jul 29; 30(4):23-9. PubMed ID: 6730403
    [Abstract] [Full Text] [Related]

  • 16. Three-year follow-up of carcinoembryonal antigen levels in the serum of patients with breast cancer.
    Lang BA, Kocent A, Nekulová M, Hlávková J.
    Neoplasma; 1984 Jul 29; 31(1):79-87. PubMed ID: 6700798
    [Abstract] [Full Text] [Related]

  • 17. Carcinoembryonic antigen in metastatic colorectal cancer.
    Hamm CM, Cripps C.
    Clin Invest Med; 1998 Jul 29; 21(4-5):186-91. PubMed ID: 9800067
    [Abstract] [Full Text] [Related]

  • 18. [The tumor markers CEA, TPA and CA 19-9 and ferritin and osteocalcin in follow-up studies in breast cancer].
    Schatz C, von Lieven H, Mulders M, Rowold J, Stracke H, Müller H, Grebe SF, Schatz H.
    Wien Klin Wochenschr; 1985 Dec 06; 97(23):873-9. PubMed ID: 3878042
    [Abstract] [Full Text] [Related]

  • 19. Carcinoembryonic antigen in patients with breast or colon cancer.
    Lee YN.
    West J Med; 1978 Nov 06; 129(5):374-80. PubMed ID: 364839
    [Abstract] [Full Text] [Related]

  • 20. [CEA and TPA in cancer of the breast. Findings and criteria of use].
    Torres Avisbal M, Ruíz de Almodovar Rivera JM, Villalba Moreno J, Olea Serrano N, Padilla Bolivar O, Pedraza Muriel V.
    Rev Esp Oncol; 1985 Nov 06; 32(2):265-80. PubMed ID: 3843460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.